fluconazole has been researched along with Diathesis in 20 studies
Fluconazole: Triazole antifungal agent that is used to treat oropharyngeal CANDIDIASIS and cryptococcal MENINGITIS in AIDS.
fluconazole : A member of the class of triazoles that is propan-2-ol substituted at position 1 and 3 by 1H-1,2,4-triazol-1-yl groups and at position 2 by a 2,4-difluorophenyl group. It is an antifungal drug used for the treatment of mucosal candidiasis and for systemic infections including systemic candidiasis, coccidioidomycosis, and cryptococcosis.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Systemic Candida infections are a major cause of infectious morbidity and mortality during chemotherapy-induced neutropenia." | 7.77 | The use of fluconazole prophylaxis in patients with chemotherapy-induced neutropenia. ( Wingard, JR, 1992) |
| "In sequential clinical trials of treatment for histoplasmosis in patients with acquired immunodeficiency syndrome, therapy with fluconazole failed in a higher proportion of patients than did therapy with itraconazole." | 7.71 | Emergence of resistance to fluconazole as a cause of failure during treatment of histoplasmosis in patients with acquired immunodeficiency disease syndrome. ( Brizendine, E; Connolly, P; Hafner, R; Smedema, M; Wheat, LJ, 2001) |
| "Fluconazole alone was not found significantly effective against C." | 5.32 | Prophylactic role of liposomized chloroquine against murine cryptococcosis less susceptible to fluconazole. ( Jabeen, R; Khan, MA; Mohammad, O, 2004) |
| " Although fluconazole use has been considered one of the main causes for the epidemiologic change in invasive candidiasis, especially in the increase of species less sensitive to this agent, this association remains unproven." | 4.84 | [Current treatment of candidemia. Role of anidulafungin]. ( Almirante, B; Pemán, J, 2008) |
| " On the basis of antifungal susceptibility profile of the isolates, caspofungin can be suggested as a useful antifungal drug for the treatment of candidemia due to fluconazole resistant species." | 3.83 | Echinocandin Susceptibility Profile of Fluconazole Resistant Candida Species Isolated from Blood Stream Infections. ( Deorukhkar, SC; Saini, S, 2016) |
| "Systemic Candida infections are a major cause of infectious morbidity and mortality during chemotherapy-induced neutropenia." | 3.77 | The use of fluconazole prophylaxis in patients with chemotherapy-induced neutropenia. ( Wingard, JR, 1992) |
| "In sequential clinical trials of treatment for histoplasmosis in patients with acquired immunodeficiency syndrome, therapy with fluconazole failed in a higher proportion of patients than did therapy with itraconazole." | 3.71 | Emergence of resistance to fluconazole as a cause of failure during treatment of histoplasmosis in patients with acquired immunodeficiency disease syndrome. ( Brizendine, E; Connolly, P; Hafner, R; Smedema, M; Wheat, LJ, 2001) |
| "Prior use of fluconazole, severe respiratory failure and hospitalization time are associated with IPA in patients with chronic pneumopathies with respiratory isolation of Aspergillus spp." | 1.38 | [Clinical factors associated with invasive pulmonary aspergillosis in patients with chronic pneumopathies and respiratory isolation of Aspergillus spp]. ( Casal, M; Castón, JJ; Linares, MJ; Rivero, A; Torre-Cisneros, J, 2012) |
| "Mucormycosis was diagnosed in the neutropenic state following allogeneic hematopoietic cell transplantation (n=3) or intense chemotherapy (n=3)." | 1.33 | Mucormycoses in patients with hematologic malignancies: an emerging fungal infection. ( Bethge, WA; Einsele, H; Hebart, H; Horger, M; Kanz, L; Kröber, SM; Schmalzing, M; Schumacher, U; Stuhler, G, 2005) |
| "Fluconazole alone was not found significantly effective against C." | 1.32 | Prophylactic role of liposomized chloroquine against murine cryptococcosis less susceptible to fluconazole. ( Jabeen, R; Khan, MA; Mohammad, O, 2004) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 3 (15.00) | 18.2507 |
| 2000's | 10 (50.00) | 29.6817 |
| 2010's | 6 (30.00) | 24.3611 |
| 2020's | 1 (5.00) | 2.80 |
| Authors | Studies |
|---|---|
| Dimopoulos, G | 1 |
| Velegraki, A | 1 |
| Falagas, ME | 1 |
| Amanati, A | 1 |
| Badiee, P | 1 |
| Jafarian, H | 1 |
| Ghasemi, F | 1 |
| Nematolahi, S | 1 |
| Haghpanah, S | 1 |
| Hamzavi, SS | 1 |
| Altintop, YA | 1 |
| Ergul, AB | 1 |
| Koc, AN | 1 |
| Atalay, MA | 1 |
| Hernández-Torres, A | 1 |
| García-Vázquez, E | 1 |
| Laso-Ortiz, A | 1 |
| Herrero-Martínez, JA | 1 |
| Gómez-Gómez, J | 1 |
| Takaoka, K | 1 |
| Nannya, Y | 1 |
| Shinohara, A | 1 |
| Arai, S | 1 |
| Nakamura, F | 1 |
| Kurokawa, M | 1 |
| Deorukhkar, SC | 1 |
| Saini, S | 1 |
| Almirante, B | 1 |
| Pemán, J | 1 |
| Chandran, SK | 1 |
| Lyons, KM | 1 |
| Divi, V | 1 |
| Geyer, M | 1 |
| Sataloff, RT | 1 |
| Takakura, S | 1 |
| Castón, JJ | 1 |
| Linares, MJ | 1 |
| Rivero, A | 1 |
| Casal, M | 1 |
| Torre-Cisneros, J | 1 |
| Fonseca, EM | 1 |
| Nuño, FJ | 1 |
| García-Alcalde, ML | 1 |
| Menéndez, MJ | 1 |
| Ozçelik, B | 1 |
| Citak, S | 1 |
| Cesur, S | 1 |
| Abbasoğlu, U | 1 |
| Içli, F | 1 |
| Khan, MA | 1 |
| Jabeen, R | 1 |
| Mohammad, O | 1 |
| Bethge, WA | 1 |
| Schmalzing, M | 1 |
| Stuhler, G | 1 |
| Schumacher, U | 1 |
| Kröber, SM | 1 |
| Horger, M | 1 |
| Einsele, H | 1 |
| Kanz, L | 1 |
| Hebart, H | 1 |
| Girmenia, C | 1 |
| Martino, P | 1 |
| Cassone, A | 1 |
| Klepser, ME | 1 |
| Lewis, RE | 1 |
| Pfaller, MA | 1 |
| Trenschel, R | 1 |
| Peceny, R | 1 |
| Runde, V | 1 |
| Elmaagacli, A | 1 |
| Dermoumi, H | 1 |
| Heintschel von Heinegg, E | 1 |
| Müller, KD | 1 |
| Schaefer, UW | 1 |
| Beelen, DW | 1 |
| Wheat, LJ | 1 |
| Connolly, P | 1 |
| Smedema, M | 1 |
| Brizendine, E | 1 |
| Hafner, R | 1 |
| Morey, A | 1 |
| Lima, C | 1 |
| Matas, B | 1 |
| Munar, MA | 1 |
| Wingard, JR | 1 |
5 reviews available for fluconazole and Diathesis
| Article | Year |
|---|---|
[Candida sp endocarditis. Experience in a third-level hospital and review of the literature].
Topics: Acute Kidney Injury; Adult; Aged; Amphotericin B; Anti-Bacterial Agents; Antifungal Agents; Bacteria | 2013 |
[Current treatment of candidemia. Role of anidulafungin].
Topics: Adult; Aged; Anidulafungin; Antifungal Agents; Candidiasis; Clinical Trials as Topic; Disease Suscep | 2008 |
[Candidosis].
Topics: Antifungal Agents; Candidiasis; Catheters; Contraindications; Cross Infection; Disease Susceptibilit | 2011 |
Therapy of Candida infections: susceptibility testing, resistance, and therapeutic options.
Topics: Antifungal Agents; Candida; Candidiasis; Disease Susceptibility; Drug Resistance, Microbial; Drug Th | 1998 |
The use of fluconazole prophylaxis in patients with chemotherapy-induced neutropenia.
Topics: Amphotericin B; Bone Marrow Transplantation; Candidiasis; Disease Susceptibility; Double-Blind Metho | 1992 |
2 trials available for fluconazole and Diathesis
| Article | Year |
|---|---|
Fungal colonization and invasive fungal infections following allogeneic BMT using metronidazole, ciprofloxacin and fluconazole or ciprofloxacin and fluconazole as intestinal decontamination.
Topics: Adolescent; Adult; Anti-Bacterial Agents; Antibiotic Prophylaxis; Antifungal Agents; Aspergillosis; | 2000 |
The use of fluconazole prophylaxis in patients with chemotherapy-induced neutropenia.
Topics: Amphotericin B; Bone Marrow Transplantation; Candidiasis; Disease Susceptibility; Double-Blind Metho | 1992 |
14 other studies available for fluconazole and Diathesis
| Article | Year |
|---|---|
A 10-year survey of antifungal susceptibility of candidemia isolates from intensive care unit patients in Greece.
Topics: Antifungal Agents; Candida; Candidiasis; Data Collection; Disease Susceptibility; Greece; Humans; In | 2009 |
Impact of antifungal stewardship interventions on the susceptibility of colonized Candida species in pediatric patients with malignancy.
Topics: Adolescent; Amphotericin B; Antifungal Agents; Antimicrobial Stewardship; Candida; Caspofungin; Chil | 2021 |
Evaluation of Candida colonization and use of the Candida Colonization Index in a paediatric Intensive Care Unit: a prospective observational study.
Topics: Adolescent; Amphotericin B; Antifungal Agents; Candida; Candidemia; Caspofungin; Child; Child, Presc | 2019 |
A novel scoring system to predict the incidence of invasive fungal disease in salvage chemotherapies for malignant lymphoma.
Topics: Adult; Aged; Aged, 80 and over; Antifungal Agents; Antineoplastic Combined Chemotherapy Protocols; C | 2014 |
Echinocandin Susceptibility Profile of Fluconazole Resistant Candida Species Isolated from Blood Stream Infections.
Topics: Antifungal Agents; Candida; Candida albicans; Candida glabrata; Candidemia; Candidiasis, Invasive; C | 2016 |
Fungal laryngitis.
Topics: Administration, Oral; Adrenal Cortex Hormones; Aged; Antifungal Agents; Candidiasis; Disease Suscept | 2009 |
[Clinical factors associated with invasive pulmonary aspergillosis in patients with chronic pneumopathies and respiratory isolation of Aspergillus spp].
Topics: Aged; Aged, 80 and over; Antifungal Agents; Aspergillus; Asthma; Bacterial Infections; Carrier State | 2012 |
[Infection due to herpes zoster and cryptococcus after initiating high-activity antiretroviral treatment].
Topics: Acquired Immunodeficiency Syndrome; Adult; AIDS-Related Opportunistic Infections; Antifungal Agents; | 2003 |
In vitro susceptibility of Candida species isolated from cancer patients to some antifungal agents.
Topics: Amphotericin B; Antifungal Agents; Candida; Disease Susceptibility; Fluconazole; Flucytosine; Humans | 2004 |
Prophylactic role of liposomized chloroquine against murine cryptococcosis less susceptible to fluconazole.
Topics: Animals; Cell Line; Chloroquine; Cryptococcosis; Cryptococcus neoformans; Disease Models, Animal; Di | 2004 |
Mucormycoses in patients with hematologic malignancies: an emerging fungal infection.
Topics: Adult; Aged; Amphotericin B; Antifungal Agents; Antineoplastic Agents; Communicable Diseases, Emergi | 2005 |
Breakthrough candidemia during antifungal treatment with fluconazole in patients with hematologic malignancies.
Topics: Candida; Candidiasis; Catheterization, Central Venous; Disease Susceptibility; Drug Resistance, Micr | 1996 |
Emergence of resistance to fluconazole as a cause of failure during treatment of histoplasmosis in patients with acquired immunodeficiency disease syndrome.
Topics: Acquired Immunodeficiency Syndrome; AIDS-Related Opportunistic Infections; Antifungal Agents; Diseas | 2001 |
[Fluconazole prophylaxis for fungal peritonitis in peritoneal dialysis].
Topics: Adult; Aged; Anti-Bacterial Agents; Antifungal Agents; Bacterial Infections; Diabetic Nephropathies; | 2001 |